What is Gritstone?
At the core of our immunotherapy strategy is our deep understanding of antigens and neoantigens, especially when it comes to pinpointing which variations will be transcribed, translated, processed, and ultimately presented on cell surfaces through Human leukocyte antigen (HLA) molecules, making them identifiable to T cells. We utilize Gritstone EDGETM, an innovative platform that leverages machine learning to facilitate this process. The development of cancer immunotherapies that target tumor-specific neoantigens is particularly challenging due to the multitude of mutations present in tumors, where only a select few translate into true tumor-specific neoantigens. To address this intricate issue, we have engineered EDGE's advanced integrated neural network model, which has been trained on millions of data points sourced from a wide array of tumor and normal tissue samples derived from various patient backgrounds. This comprehensive training significantly boosts our ability to accurately identify neoantigens and enhances the overall effectiveness of our immunotherapy approaches, ultimately aiming to provide more targeted and effective treatments for patients. By continually refining our methods and expanding our databases, we strive to stay at the forefront of cancer immunotherapy advancements.
Integrations
No integrations listed.
Similar Software to Gritstone
Google Cloud Speech-to-Text
An API driven by Google's AI capabilities enables precise transformation of spoken language into written text. This technology enhances your content with accurate captions, improves the user experience through voice-activated features, and provides valuable analysis of customer interactions that can lead to better service. Utilizing cutting-edge algorithms from Google's deep learning neural networks, this automatic speech recognition (ASR) system stands out as one of the most sophisticated available. The Speech-to-Text service supports a variety of applications, allowing for the creation, management, and customization of tailored resources. You have the flexibility to implement speech recognition solutions wherever needed, whether in the cloud via the API or on-premises with Speech-to-Text O-Prem. Additionally, it offers the ability to customize the recognition process to accommodate industry-specific jargon or uncommon vocabulary. The system also automates the conversion of spoken figures into addresses, years, and currencies. With an intuitive user interface, experimenting with your speech audio becomes a seamless process, opening up new possibilities for innovation and efficiency. This robust tool invites users to explore its capabilities and integrate them into their projects with ease.
Learn more
QUALO
QUALO is a versatile cloud-based software solution aimed at addressing significant challenges related to data output and visualization within behavioral health, community health, and healthcare sectors. Its main objective is to provide meaningful insights while ensuring that clients, staff, administrators, and funders are not inundated with excessive information.
The platform merges data collection capabilities with tailored evidence-based practice supports, allowing for the accurate gathering of relevant data precisely when needed. Furthermore, it features specialized care coordination tools specifically designed to meet the unique needs of human service providers.
A major advantage of QUALO is its ability to integrate smoothly with various systems, particularly electronic health records (EHRs). By serving as a centralized data entry hub, it aims to mitigate the common shortcomings found in the data output and visualization of EHRs. In addition, QUALO's mobile-optimized interface facilitates access from a variety of devices, thus improving the overall efficiency of the data collection workflow. This adaptability ensures that users can engage with the platform whenever and wherever they need to make informed decisions.
Learn more
Bruker Drug Discovery
The journey of bringing a new drug to market involves a complex, time-consuming, and expensive process that is subject to stringent regulations, often taking more than ten years to complete. The success of this venture largely depends on the early acquisition of accurate analytical data, which is essential for making informed choices during the early phases of development and for minimizing the chances of failures in later stages. Typically, the modern drug development process adheres to a systematic approach, starting with the identification of a biological target that becomes the centerpiece of the research efforts. This foundational step requires a deep understanding of the properties of potential candidates to efficiently and effectively identify the most promising options. Once the biological target is identified, the subsequent challenge is to find the most advantageous lead molecules, which includes discovering potential drug candidates that may consist of small organic compounds or biologic entities that show therapeutic potential. Additionally, this entire process highlights the necessity for cross-disciplinary collaboration and innovative thinking, emphasizing the intricate nature of converting a scientific concept into an effective medication. Ultimately, the path from idea to treatment is not just about scientific discovery but also about navigating the complexities of regulatory landscapes and market dynamics.
Learn more
Genedata Biologics
Genedata Biologics® significantly advances the creation of biotherapeutics such as bispecifics, ADCs, TCRs, CAR-Ts, and AAVs, offering an all-encompassing solution for the sector. Esteemed as a premier platform in its domain, it seamlessly integrates all discovery processes, empowering researchers to focus on true innovation. By employing a cutting-edge system specifically designed to digitize the biotherapeutic discovery journey, research timelines can be notably expedited. This platform streamlines complex R&D activities by aiding in the design, tracking, testing, and evaluation of new biotherapeutic entities. It accommodates a variety of formats, including antibodies, bi- or multi-specifics, ADCs, novel scaffolds, and therapeutic proteins, along with engineered therapeutic cell lines like TCRs and CAR-T cells. As a fully integrated data backbone, Genedata Biologics links all R&D activities, from library design and immunization to selection and panning, molecular biology, screening, protein engineering, expression, purification, and analytics, resulting in thorough evaluations of candidate developability and manufacturability. This comprehensive integration not only enables researchers to make well-informed choices but also fosters a culture of exploration and advancement in biotherapeutic innovation. Ultimately, the synergy of these capabilities positions Genedata Biologics as a vital asset in the competitive landscape of biopharmaceutical development.
Learn more
Screenshots and Video
Company Facts
Company Name:
Gritstone bio
Date Founded:
2015
Company Location:
United States
Company Website:
gritstonebio.com/scientific-platform/
Product Details
Deployment
SaaS
Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English